Pan-European Survey on the Under Treatment of Hypercholesterolemia

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

NCT01075594 ·Status: COMPLETED

A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

NCT04964557 ·Status: COMPLETED ·Phase: PHASE2

National Survey on Dyslipidemic Patients

NCT00701402 ·Status: COMPLETED

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

NCT01604733 ·Status: COMPLETED

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

NCT00536796 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

NCT05930028 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)

NCT00705081 ·Status: COMPLETED

Ezetimibe-Rosuvastatin Evaluation Study

NCT03947866 ·Status: UNKNOWN

Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia

NCT03429998 ·Status: COMPLETED ·Phase: PHASE3

An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

NCT01206231 ·Status: COMPLETED

A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

NCT00705211 ·Status: COMPLETED

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

NCT00536965 ·Status: COMPLETED

Cross-over Study of Coronary Risk Factors With a Polypill

NCT05030818 ·Status: RECRUITING ·Phase: PHASE4

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

NCT00535405 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

NCT07000123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

NCT00723723 ·Status: COMPLETED

Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

NCT00654095 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

NCT00327691 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

NCT00257686 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946 ·Status: COMPLETED ·Phase: PHASE3

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

NCT00726856 ·Status: COMPLETED

A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

NCT02550288 ·Status: COMPLETED ·Phase: PHASE3

Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

NCT02942602 ·Status: COMPLETED ·Phase: NA

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

NCT01013103 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

NCT05206578 ·Status: UNKNOWN ·Phase: PHASE3